期刊文献+

miR-139-5p在胃癌中的表达及意义 被引量:5

Clinical significance of abnormal expression of mi R-139-5p in gastric cancer
下载PDF
导出
摘要 目的分析mi R-139-5p在胃癌中的表达及其与临床病理特征的关系。方法采用逆转录实时定量PCR方法检测mi R-139-5p在胃癌及其癌旁正常组织中的表达量,并分析其与临床病理特征关系。此外检测4株胃癌细胞与正常人胃上皮细胞中mi R-139-5p的表达。结果与癌旁正常组织比较,mi R-139-5p在胃癌组织中表达下调;有无淋巴结转移以及TNM分期间mi R-139-5p的表达差异有统计学意义(P<0.05);而不同性别、年龄、肿瘤大小以及肿瘤分化程度间mi R-139-5p的表达差异无统计学意义(P>0.05)。mi R-139-5p在胃癌细胞株中表达下调。结论 mi R-139-5p在胃癌组织和细胞中表达下调,并与胃癌的淋巴结转移及TNM分期密切相关,其可能参与了胃癌的转移过程。 Objective To investigate the expression of miR -139-5p and its association with clinicopathologic features in gastric cancer.Methods The expression level of miR -139 -5p in 30 cases of gastric cancer and matched non -tumor adjacent tissue specimens was examined using reverse transcription real -time PCR.The correlation between the expression of miR -139 -5p and the clinicopathologic features of gastric cancer was studied .The expression of miR -139 -5p in four gastric cancer cell lines and normal human gastric epithelial cells was also detected .Results The ex-pression of miR -139 -5p was significantly down -regulated in tumor tissues than that in the adjacent tissues (P 〈0.05).There was significant difference in miR -139 -5p expression among cases w /o lymph node metastasis group and with different TNM stages (P 〈0.05).However, there was no significant difference in miR -139 -5p expression among cases with different genders, ages, tumor sizes or tumor differentiation (P &gt;0.05).The expression of miR -139 -5p in gastric cancer cell lines was significantly down -regulated than that of normal human gastric epithelial cells .Conclusion The expression of miR -139 -5p in gastric cancer tissues and cells is down -regulated, and associated with metastasis .
出处 《广东医学》 CAS 北大核心 2015年第3期371-374,共4页 Guangdong Medical Journal
基金 广东省医学科研基金资助项目(编号:B2014095)
关键词 MICRORNA 胃癌 转移 microRNA gastric cancer metastasis
  • 相关文献

参考文献11

  • 1JEMAL A, SIEGEL R, XU J, et al. Cance r stastistics, 2010 [J]. CA Cancer J Clin, 2010, 60(5): 277-300.
  • 2KRISHNAN K, STEPTOE A L, MARTIN H C, et al. miR - 139 - 5p is a regulator of metastatic pathways in breast cancer[ J ]. RNA, 2013, 19(12) : 1767 - 1780.
  • 3WONG C C, WONG C M, TUNG E K, et al. The micmRNA miR - 139 suppresses metastasis and progression of hepatocel[u[ar carcino- ma by down - regulating Rho - kinase 2 [ J ]. Gastroenterology, 2011, 140(1): 322-331.
  • 4LIU L Y, WANG W, ZHAO L Y, et al. miR - 126 inhibits growth of SGC - 7901 cells by synergistically targeting the onco- genes PI3 KR2 and Crk, and the tumor suppressor PLK2 [J]. Int J Oncol,2014, 45(3) : 1257 - 1265.
  • 5TSAI M M, WANG C S, TSAI C Y, et al, MicroRNA- 196a/- 196b promote cell metastasis via negative regulation of radixin in human gastric cancer[ J. Cancer Lett, 2014, 351 (2): 222- 231.
  • 6SHEN K, MAO R, MA L, et al. Post -transcriptional regulation of the tumor suppressor miR - 139 - 5p and a network of miR -139- 5p- mediated mRNA interactions in colorectal cancer [ J ]. FEBS J, 2014, doi: 10. llll/febs. 12880.
  • 7LIU R, YANG M,MENG Y, et al. Tumor - suppressive function of miR- 139 -5p in esophageal squamous cell carcinoma [ J]. PLoS One, 2013, 8(10) :e77068.
  • 8GUO J, MIAO Y, XIAO B, et al. Differential expression of mi- croRNA species in human gastric cancer versus nontumorous tis- sues[ J. J Gastroenteml Hepatol, 2009,24 (4) : 652 - 657.
  • 9BAO W, FU H J, XIE Q S, et al. HER2 interacts with CD44 toup -regulate CXCR4 via epigenetic silencing of microRNA - 139 in gastric cancer ceils [ J. Gastroenterology, 2011, 141 (6) : 2076 - 2087.
  • 10YU S L, CHEN H Y, CHANG G C, et al. MicroRNA Signature Predicts Survivaland Relapse in Lung Cancer [ J ]. Cancer Cell, 2008, 13(1) : 48 -57.

二级参考文献9

  • 1LI X, ZHANG Y, ZHANG H, et al. miRNA -223 promotes gas- tric cancer invasion and metastasis by targeting tumor suppressor EPB41L3[J]. Mol Cancer Res, 2011, 9(7) : 824 -833.
  • 2OSMAN A. MieroRNAs in health and disease - -basic science and clinical applications[J]. Clin Lab, 2012, 58(5/6) : 393 -402.
  • 3KONG Y W, FERLAND MCCOLLOUGH D, JACKSON T J, et al. microRNAs in cancer management [ J]. Lancet Oncol, 2012, 13(6) : e249 - e258.
  • 4FUJII Y, YADA M, NISHIYAMA M, et al. Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin - de- pendent degradation [ J ]. Cancer Sci, 2006, 97 (8) : 729 - 736.
  • 5YOKOBORI T, MIMORI K, IWATSUKI M, et al. p53 - Altered FBXW7 expression determines poor prognosis in gastric cancer ca- ses[J]. Cancer Res, 2009, 69(9): 3788-3794.
  • 6NAKAYAMA K I, NAKAYAMA K. Ubiquitin ligases: cell -cycle control and cancer[J]. Nat Rev Cancer, 2(136, 6(5) : 369 -381.
  • 7孙芳,郑晓飞,孙志贤.miRNA参与p53基因调控网络研究进展[J].军事医学科学院院刊,2009,33(4):373-377. 被引量:3
  • 8张安玲,浦佩玉.微RNA-106b~25基因簇在肿瘤中的研究进展[J].国际肿瘤学杂志,2011,38(3):163-166. 被引量:3
  • 9熊青,徐龙.血清microRNAs在胃肠道疾病中的意义[J].世界华人消化杂志,2012,20(22):2043-2049. 被引量:7

共引文献2

同被引文献28

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部